This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
What I mean is they won't eliminate overweight people, as the results aren't that good.
Moreover, it was natural for people not to become obese with very few exceptions. The drug is merely fixing the issues that we have created in recent years. It is not an improvement, merely preventing more harm that we are causing to ourselves.
That's the hope.
More options
Context Copy link
More options
Context Copy link
More options
Context Copy link